Recent News

• 03.25.2025 - Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline with Five Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025
• 03.25.2025 - Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline with Five Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025
• 03.12.2025 - Leerink's Global Healthcare Conference 2025
• 03.12.2025 - Leerink's Global Healthcare Conference 2025
• 02.27.2025 - Tango Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Highlights
• 02.27.2025 - Tango Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Highlights
• 02.20.2025 - Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences
• 02.20.2025 - Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences
• 02.05.2025 - Guggenheim Securities SMID Cap Biotech Conference
• 02.05.2025 - Guggenheim Securities SMID Cap Biotech Conference

Recent Filings

• 02.27.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 02.27.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.27.2025 - 8-K Current report
• 02.27.2025 - EX-99.1 EX-99.1
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities